Back

Targeting Wnt Signaling and DNAJB6/MRJ-L as a Dual Anti-RSV Strategy: Insights into a Positive Regulatory Loop

Lu, C.-Y.; Lai, P.-Y.; Huang, J.-M.; Chang, L.-Y.; Yen, T.-Y.; Tarn, W.-Y.; Huang, L.-M.

2025-04-01 pathology
10.1101/2025.03.27.645670 bioRxiv
Show abstract

Respiratory syncytial virus (RSV) is a major cause of severe respiratory infections, yet effective treatments are lacking. We found that the molecular chaperon DNAJB6/MRJ plays an essential role in RSV replication. Depletion of the long isoform of MRJ (MRJ-L) suppresses RSV replication. Transcriptomic analysis revealed that MRJ-L depletion downregulates Wnt signaling pathways. A pharmacological inhibitor of Wnt signaling suppressed RSV propagation and unexpectedly reduced MRJ-L expression, suggesting a positive regulatory loop between Wnt signaling and MRJ-L expression. Notably, simultaneous inhibition of Wnt signaling and MRJ-L additively suppressed RSV replication, suggesting that the Wnt-MRJ-L axis may serve as a new therapeutic target. This study provides insights into host-RSV interactions and potential antiviral strategies. Author SummaryThe molecular chaperone DNAJB6/MRJ has been implicated in the replication of respiratory syncytial virus (RSV), although the precise mechanisms remain unclear. In this study, we discovered that MRJ may influence RSV replication via Wnt signaling pathways. Specifically, we demonstrated that Wnt signaling inhibitor Wnt-C59 significantly reduced RSV replication by suppressing the synthesis of viral mRNA and genome/antigenome. Moreover, a positive feedback loop of the Wnt-MRJ axis may play a critical role in regulating RSV replication. Importantly, RSV replication was suppressed additively by inhibition of Wnt signaling and depletion of MRJ-L. Thus, a dual-targeted therapeutic approach may be effective in combating RSV infections.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Pathogens
820 papers in training set
Top 0.7%
18.1%
2
International Journal of Molecular Sciences
494 papers in training set
Top 0.6%
7.1%
3
PLOS ONE
5266 papers in training set
Top 27%
6.1%
4
Journal of Virology
499 papers in training set
Top 1%
5.4%
5
Viruses
332 papers in training set
Top 1%
4.4%
6
Journal of Medical Virology
140 papers in training set
Top 0.6%
4.0%
7
Cells
249 papers in training set
Top 1%
3.2%
8
iScience
1154 papers in training set
Top 8%
3.1%
50% of probability mass above
9
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.2%
2.7%
10
Life Sciences
27 papers in training set
Top 0.3%
2.3%
11
International Journal of Biological Sciences
10 papers in training set
Top 0.1%
2.1%
12
Scientific Reports
3612 papers in training set
Top 49%
2.1%
13
Virulence
25 papers in training set
Top 0.3%
1.9%
14
Biochemical and Biophysical Research Communications
84 papers in training set
Top 1%
1.7%
15
Virology
61 papers in training set
Top 0.7%
1.7%
16
Virus Research
37 papers in training set
Top 0.4%
1.7%
17
eLife
5828 papers in training set
Top 51%
1.6%
18
RNA Biology
78 papers in training set
Top 0.8%
1.5%
19
Immunity, Inflammation and Disease
10 papers in training set
Top 0.1%
1.5%
20
mBio
833 papers in training set
Top 8%
1.5%
21
Science Bulletin
21 papers in training set
Top 0.2%
1.3%
22
Frontiers in Microbiology
427 papers in training set
Top 6%
1.3%
23
Microorganisms
106 papers in training set
Top 3%
1.1%
24
Cancers
213 papers in training set
Top 4%
1.1%
25
Frontiers in Medicine
120 papers in training set
Top 3%
1.1%
26
Frontiers in Molecular Biosciences
102 papers in training set
Top 2%
1.0%
27
Biomolecules
100 papers in training set
Top 2%
0.9%
28
The FEBS Journal
93 papers in training set
Top 2%
0.8%
29
The FASEB Journal
194 papers in training set
Top 6%
0.8%
30
Frontiers in Immunology
638 papers in training set
Top 10%
0.8%